INDERPAL SINGH CHHABRA M.D. NPI 1497754881

NPI Details

Inderpal Singh Chhabra, M.D. is an internal medicine in New Hyde Park, NY with 33 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. Inderpal Singh Chhabra, M.D. NPI is 1497754881. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

26619 UNION TPKE
NEW HYDE PARK, NY
ZIP 11040-426
Phone: (718) 347-0434
Fax: (718) 347-0517

The NPI 1497754881 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Hospital discharge day management, 30 minutes or less (HCPCS:99238)
• Annual depression screening, 15 minutes (HCPCS:G0444)
• Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes (HCPCS:G0396)
• Urinalysis, manual test (HCPCS:81002)
• Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days (HCPCS:99454)
• Annual alcohol misuse screening, 15 minutes (HCPCS:G0442)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Management using the results of remote vital sign monitoring per calendar month, first 20 minutes (HCPCS:99457)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Advance care planning, first 30 minutes (HCPCS:99497)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Ultrasound of heart with color-depicted blood flow, rate, direction and valve function (HCPCS:93306)
• Influenza vaccine, quadrivalent derived from cell cultures (HCPCS:90756)
• Transitional care management services for problem of high complexity (HCPCS:99496)
• Severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted, for intramuscular use (HCPCS:91300)
• Ultrasound study of arm and leg arteries (HCPCS:93922)
• Insertion of needle into vein (3 years or older) (HCPCS:36410)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Testing of autonomic nervous system function and heart rate response to deep breathing (HCPCS:95921)
• Testing of autonomic (sympathetic) nervous system function (HCPCS:95923)
• Ultrasound of both sides of head and neck blood flow (HCPCS:93880)
• Electrocardiogram (ecg) 1 to 3 leads with review by physician (HCPCS:93040)
• Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment (HCPCS:99453)
• Nerve conduction, 9-10 studies (HCPCS:95911)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Telephone medical discussion with physician, 21-30 minutes (HCPCS:99443)
• Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) (HCPCS:87880)
• Removal of impacted ear wax by washing (HCPCS:69209)
• Complete ultrasound study of arm and leg arteries (HCPCS:93923)
• Ultrasound of leg arteries or artery grafts (HCPCS:93925)

The enumeration date for this NPI number is 7/18/2005 and was last updated on 8/5/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.